National Cancer Institute: Paul Calabresi Career Development Award for Clinical Oncology

This grant offered by the National Cancer Institute aims to increase the number of clinician-scientists in clinical and translational cancer research. The Paul Calabresi Career Development Award for Clinical Oncology (PCACO) supports the career development of cancer researchers. Applications are accepted until June 17, 2024.

Opportunity ID: 339379

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	PAR-22-136
Funding Opportunity Title::	Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Education
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.398 — Cancer Research Manpower
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 1
Posted Date::	Apr 11, 2022
Last Updated Date::	Apr 11, 2022
Original Closing Date for Applications::	Jun 17, 2024
Current Closing Date for Applications::	Jun 17, 2024
Archive Date::	Jul 23, 2024
Estimated Total Program Funding::
Award Ceiling::	$
Award Floor::	$

Eligibility

Eligible Applicants::

Special district governments

Additional Information on Eligibility::

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name::	National Institutes of Health
Description::	The purpose of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research, and to promote their career development as cancer researchers.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 1		Apr 11, 2022

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:
Competition ID:	FORMS-G
Competition Title:	Use for due dates on or before January 24, 2023
Opportunity Package ID:	PKG00273248
Opening Date:	May 15, 2022
Closing Date:	Jan 24, 2023
Agency Contact Information::	eRA Service Desk Monday to Friday 7 am to 8 pm ET http://grants.nih.gov/support/
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V5.0] Project/Performance Site Location(s) [V4.0] Research And Related Other Project Information [V1.4] Research and Related Senior/Key Person Profile (Expanded) [V4.0] PHS 398 Cover Page Supplement [V5.0] PHS 398 Research Training Program Plan [V4.0] Research & Related Budget [V3.0] PHS Human Subjects and Clinical Trials Information [V3.0]
optional_forms	R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V3.0] PHS Assignment Request Form [V3.0]

Package No: 2